Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IRIDEX Corporation - Common Stock (NQ:IRIX)

1.060 +0.020 (+1.92%)
Streaming Delayed Price Updated: 10:14 AM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about IRIDEX Corporation - Common Stock

< Previous 1 2 Next >
Iridex to Report Third Quarter 2025 Financial Results on November 11, 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex Corporation Receives Formal Notification of Nasdaq Listing Compliance
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Second Quarter 2025 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Second Quarter 2025 Financial Results on August 12, 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports First Quarter 2025 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Preliminary Operational and Financial Results for the First Quarter 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Host Strategic Vision Call on April 16, 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Fourth Quarter and Full Year 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Strategic Investment in the Company
From IRIDEX Corporation
Via GlobeNewswire
Iridex Comments on Recent Stock Price Volatility
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
From IRIDEX Corporation
Via GlobeNewswire
Iridex Comments on Changing Glaucoma Reimbursement Landscape
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Third Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Appoints Patrick Mercer as Chief Executive Officer
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Second Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces Convertible Note Financing
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report Second Quarter 2024 Financial Results on August 8, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports First Quarter 2024 Financial Results
From IRIDEX Corporation
Via GlobeNewswire
Iridex to Report First Quarter 2024 Financial Results on May 14, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Reports Fourth Quarter and Full Year 2023 Financial Results
Advances strategic review to unlock shareholder value 
From IRIDEX Corporation
Via GlobeNewswire
Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024
From IRIDEX Corporation
Via GlobeNewswire
Iridex Corporation Receives European Patent on MicroPulse Technology
The Advanced Short Pulse Laser System 
From IRIDEX Corporation
Via GlobeNewswire
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
From IRIDEX Corporation
Via GlobeNewswire
Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma
From IRIDEX Corporation
Via GlobeNewswire
Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation
Action Retains Full Patient Access to MicroPulse® Transscleral Laser Treatment 
From IRIDEX Corporation
Via GlobeNewswire
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.